Bioactive Lipids, LPC and LPA, Are Novel Prometastatic Factors and Their Tissue Levels Increase in Response to Radio/Chemotherapy
暂无分享,去创建一个
M. Ratajczak | A. Morris | A. Abdel-Latif | Zachariah P Sellers | G. Schneider | Zachariah P. Sellers | Gabriela Schneider
[1] M. Ratajczak,et al. Induction of a tumor-metastasis-receptive microenvironment as an unwanted and underestimated side effect of treatment by chemotherapy or radiotherapy , 2013, Journal of Ovarian Research.
[2] Mark J. Bowser,et al. The paternally imprinted DLK1-GTL2 locus is differentially methylated in embryonal and alveolar rhabdomyosarcomas , 2013, International journal of oncology.
[3] B. Brors,et al. Autotaxin is expressed in FLT3-ITD positive acute myeloid leukemia and hematopoietic stem cells and promotes cell migration and proliferation. , 2013, Experimental hematology.
[4] P. Houghton,et al. Bioactive Lipids S1P and C1P Are Prometastatic Factors in Human Rhabdomyosarcoma, and Their Tissue Levels Increase in Response to Radio/Chemotherapy , 2013, Molecular Cancer Research.
[5] M. Ratajczak,et al. Ceramide‐1‐Phosphate Regulates Migration of Multipotent Stromal Cells and Endothelial Progenitor Cells—Implications for Tissue Regeneration , 2013, Stem cells.
[6] Zhi-wei Feng,et al. Neural cell adhesion molecule modulates mesenchymal stromal cell migration via activation of MAPK/ERK signaling. , 2012, Experimental cell research.
[7] C. Parish,et al. Upregulation of heparanase in high-glucose-treated endothelial cells promotes endothelial cell migration and proliferation and correlates with Akt and extracellular-signal-regulated kinase phosphorylation , 2012, Molecular vision.
[8] D. Im,et al. Orally active lysophosphatidic acid receptor antagonist attenuates pancreatic cancer invasion and metastasis in vivo , 2012, Cancer science.
[9] E. Blalock,et al. Autotaxin and its product lysophosphatidic acid suppress brown adipose differentiation and promote diet-induced obesity in mice. , 2012, Molecular endocrinology.
[10] Shiaw-Min Hwang,et al. Lysophosphatidic Acid Induces Erythropoiesis through Activating Lysophosphatidic Acid Receptor 3 , 2011, Stem cells.
[11] Albert Zlotnik,et al. Homeostatic chemokine receptors and organ-specific metastasis , 2011, Nature Reviews Immunology.
[12] Tao Wu,et al. Binding of Autotaxin to Integrins Localizes Lysophosphatidic Acid Production to Platelets and Mammalian Cells* , 2011, The Journal of Biological Chemistry.
[13] M. Ratajczak,et al. CONDITIONING FOR HEMATOPOIETIC TRANSPLANTATION ACTIVATES THE COMPLEMENT CASCADE AND INDUCES A PROTEOLYTIC ENVIRONMENT IN BONE MARROW – A NOVEL ROLE FOR BIOACTIVE LIPIDS AND SOLUBLE C5b-C9 AS HOMING FACTORS , 2011, Leukemia.
[14] L. Schang,et al. Lysophosphatidate Induces Chemo-Resistance by Releasing Breast Cancer Cells from Taxol-Induced Mitotic Arrest , 2011, PloS one.
[15] P. Houghton,et al. National Cancer Institute pediatric preclinical testing program: Model description for in vitro cytotoxicity testing , 2011, Pediatric blood & cancer.
[16] M. Ratajczak,et al. Overlapping and distinct role of CXCR7‐SDF‐1/ITAC and CXCR4‐SDF‐1 axes in regulating metastatic behavior of human rhabdomyosarcomas , 2010, International journal of cancer.
[17] Yuanda Song,et al. Autotaxin: a protein with two faces. , 2010, Biochemical and biophysical research communications.
[18] C. Silliman,et al. Lysophosphatidylcholines activate G2A inducing G(αi)₋₁-/G(αq/)₁₁- Ca²(+) flux, G(βγ)-Hck activation and clathrin/β-arrestin-1/GRK6 recruitment in PMNs. , 2010, The Biochemical journal.
[19] M. Ratajczak,et al. Macrophage Migration Inhibitory Factor Is Secreted by Rhabdomyosarcoma Cells, Modulates Tumor Metastasis by Binding to CXCR4 and CXCR7 Receptors and Inhibits Recruitment of Cancer-Associated Fibroblasts , 2010, Molecular Cancer Research.
[20] G. Prestwich,et al. Inhibition of tumor growth and angiogenesis by a lysophosphatidic acid antagonist in an engineered three‐dimensional lung cancer xenograft model , 2010, Cancer.
[21] M. Ratajczak,et al. PLASMA SPHINGOSINE 1-PHOSPHATE IS A MAJOR CHEMOATTRACTANT THAT DIRECTS EGRESS OF HEMATOPOIETIC STEM PROGENITOR CELLS FROM BONE MARROW AND ITS LEVEL IN PERIPHERAL BLOOD INCREASES DURING MOBILIZATION DUE TO ACTIVATION OF COMPLEMENT CASCADE/MEMBRANE ATTACK COMPLEX , 2010, Leukemia.
[22] Kyoko Noguchi,et al. LPA receptors: subtypes and biological actions. , 2010, Annual review of pharmacology and toxicology.
[23] N. Samadi,et al. Inhibition of autotaxin production or activity blocks lysophosphatidylcholine‐induced migration of human breast cancer and melanoma cells , 2009, Molecular carcinogenesis.
[24] G. Ferry,et al. S32826, A Nanomolar Inhibitor of Autotaxin: Discovery, Synthesis and Applications as a Pharmacological Tool , 2008, Journal of Pharmacology and Experimental Therapeutics.
[25] A. Tucker,et al. Lysophosphatidic acid (LPA) and angiogenesis , 2008, Angiogenesis.
[26] N. Dhalla,et al. Mechanisms of the lysophosphatidic acid-induced increase in [Ca2+]i in skeletal muscle cells , 2008, Journal of cellular and molecular medicine.
[27] K. Kamata,et al. Role of lysophosphatidylcholine (LPC) in atherosclerosis. , 2007, Current medicinal chemistry.
[28] Feng Hao,et al. Lysophosphatidic acid induces prostate cancer PC3 cell migration via activation of LPA(1), p42 and p38alpha. , 2007, Biochimica et biophysica acta.
[29] M. Jauhiainen,et al. Identification of alpha-1 acid glycoprotein as a lysophospholipid binding protein: a complementary role to albumin in the scavenging of lysophosphatidylcholine. , 2006, Biochemistry.
[30] F. Huang,et al. Lysophosphatidylcholine impairs endothelial barrier function through the G protein-coupled receptor GPR4. , 2006, American journal of physiology. Lung cellular and molecular physiology.
[31] A. Abdel‐Mageed,et al. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation. , 2005, Cancer research.
[32] P. Houghton,et al. Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy. , 2003, Cancer research.
[33] K. Fukuzawa,et al. Identification of Human Plasma Lysophospholipase D, a Lysophosphatidic Acid-producing Enzyme, as Autotaxin, a Multifunctional Phosphodiesterase* , 2002, The Journal of Biological Chemistry.
[34] Oana A. Tomescu,et al. CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion. , 2002, Blood.
[35] G. Mills,et al. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production , 2002, The Journal of cell biology.
[36] N. Sugimoto,et al. The Edg family G protein-coupled receptors for lysophospholipids: their signaling properties and biological activities. , 2002, Journal of biochemistry.
[37] A. Sandberg,et al. Hematologic masquerade of rhabdomyosarcoma , 2001, American journal of hematology.
[38] H. Koh,et al. Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[39] H. Zhao,et al. Proliferative and apoptotic differences between alveolar rhabdomyosarcoma subtypes: a comparative study of tumors containing PAX3-FKHR or PAX7-FKHR gene fusions. , 2001, Medical and pediatric oncology.
[40] Je‐ho Lee,et al. 17&bgr;-estradiol inhibits proliferation of cultured vascular smooth muscle cells induced by lysophosphatidylcholine via a nongenomic antioxidant mechanism , 2001, Menopause.
[41] G. Pei,et al. Lysophosphatidylcholine activates p38 and p42/44 mitogen-activated protein kinases in monocytic THP-1 cells, but only p38 activation is involved in its stimulated chemotaxis. , 2000, Circulation research.
[42] M. Obinata,et al. Sphingosine-1-phosphate and lysophosphatidic acid trigger invasion of primitive hematopoietic cells into stromal cell layers. , 2000, Blood.
[43] G. Mills,et al. Lysophospholipid Growth Factors in the Initiation, Progression, Metastases, and Management of Ovarian Cancer , 2000, Annals of the New York Academy of Sciences.
[44] K. Hirata,et al. Lysophosphatidylcholine inhibits endothelial cell migration and proliferation via inhibition of the extracellular signal-regulated kinase pathway. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[45] M. Miyazaki,et al. Plasma human hepatocyte growth factor concentrations in patients with biliary obstruction , 2000, Journal of gastroenterology and hepatology.
[46] Y. Nabeshima,et al. Lysophosphatidic acid and bFGF control different modes in proliferating myoblasts , 1996, The Journal of cell biology.
[47] L. Helman,et al. In vivo treatment with antibody against IGF-1 receptor suppresses growth of human rhabdomyosarcoma and down-regulates p34cdc2. , 1994, Cancer research.
[48] J. Biegel,et al. Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. , 1994, Cancer research.
[49] E. Kohn,et al. Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[50] M. Lagarde,et al. Characterization of plasma unsaturated lysophosphatidylcholines in human and rat. , 2000, The Biochemical journal.